Antiviral / immunomodulator
Inosine pranobex
Brand names: Imunovir
Adult dose
Dose: 1g QDS for 7–14 days (up to 4g/day)
Route: PO
Frequency: QDS
Clinical pearls
- Mucocutaneous HSV; SSPE (off-label); limited evidence
Contraindications
- Hyperuricaemia/gout
- Severe renal impairment
Side effects
- Hyperuricaemia
- Nausea
- Headache
- Joint pain
Interactions
- Allopurinol may increase uric acid effect
- Drugs causing hyperuricaemia
Monitoring
- U&E
- Uric acid
Reference: BNF; https://bnf.nice.org.uk/drugs/inosine-pranobex/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023